Green epithelium revealed by narrow-band imaging (NBI): a feature for practical assessment of extent of gastric cancer after H. pylori eradication

Abstract

Background and study aims Assessment of the extent of gastric cancer detected by endoscopy after successful eradication of H. pylori is often difficult even with narrow-band imaging (NBI)-magnifying endoscopy. Using the latter modality, it has often been noted that the cancerous area has a brownish color surrounded by green epithelium (GE). If the histological origin of this GE could be clarified, it could be of practical use for endoscopic assessment of the extent of cancer.

Materials and methods The endoscopic appearance of gastric cancer after eradication therapy was classified into four types: (A) cancer brownish, surrounding mucosa green; (B) cancer brownish, surrounding mucosa brownish; (C) cancer green, surrounding mucosa brownish; and (D) cancer green, surrounding mucosa green. A histological series of sections taken from tissues in each endoscopic view was stained with HE, and also for CDX2, MUC2, CD10 and MUC5AC. Staining intensity was evaluated by microscopy using a visual analog scale ranging from 0 to 3+: intensities of 0 and 1+ were rated as negative, and those of 2+ and 3+ as positive. Positive or negative immunostaining was examined for each type of endoscopic appearance A – D.

Results Among 42 lesions examined, 16 were type A, 18 type B, 6 type C and 2 type D. MUC2 was positive in the surrounding mucosa in 100 % of type A and D cases, but in only 28 % and 17 % of type B and C cases, respectively.

Conclusions GE observed by NBI-endoscopy corresponds to MUC2-positive mucosa and is thought to be a feature for practical assessment of the extent of cancer.

• References

• 1 Saka A, Yagi K, Nimura S. Endoscopic and histological features of gastric cancers after successful Helicobacter pylori eradication therapy. Gastric Cancer 2016; 19: 524-530
• 2 Kaise M, Kato M, Urashima M. et al. Magnifying endoscopy combined with narrow-band imaging for differential diagnosis of superficial depressed gastric lesions. Endoscopy 2009; 41: 310-315
• 3 Yagi K, Nakamura A, Sekine A. et al. Magnifying endoscopy with narrow band imaging for early differentiatedadenocarcinoma. Dig Endosc 2009; 20: 115-122
• 4 Silberg DG, Swain GP, Suh ER. et al. Cdx1 and cdx2 expression during intestinal development. Gastroenterology 2000; 119: 961-971
• 5 Tsukamoto T, Mizoshita T, Tatematsu M. Gastric-and-intestinal mixed type intestinal metaplasia:aberrant expression of transcription factors and stem cell intestinalization. Gastric Cancer 2006; 9: 156-166
• 6 Kobayashi M, Hashinoto S, Nishikura K. et al. Magnifying narrow-band imaging of surface maturation in early differentiated-type gastric cancers after Helicobacter pylori eradication. J Gastroenterol 2013; 48: 1332-1342
• 7 Uedo N, Ishihara R, Iishi H. et al. A new method of diagnosing gastric intestinal metaplasia: narrow-band imaging with magnifying endoscopy. Endoscopy 2006; 38: 819-824
• 8 Eda A, Osawa H, Yanaka I. et al. Expression of homeobox gene CDX2 precedes that of CDX1 during the progression of intestinal metaplasia. J Gastroenterol 2002; 37: 94-100
• 9 Satoh K, Mutoh H, Eda A. et al. Aberrant expression of CDX2 in the gastric mucosa with and without intestinal metaplasia: effect of eradication of Helicobacter pylori. Helicobacter 2002; 7: 192-198
• 10 Hayakawa M, Nishikura K, Ajioka Y. et al. Re-evaluation of phenotypic expression in differentiated-type early adenocarcinoma of the stomach. Pathol Int 2017; 67: 131-140
• 11 Mizoshita T, Inada K, Tsukamoto T. et al. Expression of the intestine-specific transcription factors, Cdx1 and Cdx2, correlates shift to an intestinal phenotype in gastric cancer cells. J Cancer Res Clin Oncol 2004; 130: 29-36
• 12 Mizoshita T, Tsukamoto T, Nakanishi H. et al. Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis. J Cancer Res Clin Oncol 2003; 129: 727-734
• 13 Mizoshita T, Tsukamoto T, Inada K. et al. Immunohistochemically detectable Cdx2 is present in intestinal phenotypic elements in early gastric cancers of both differentiated and undifferentiated types, with no correlation to non-neoplastic surrounding mucosa. Pathol Int 2004; 54: 392-400
• 14 Park DY, Srivastava A, Kim GH. et al. CDX2 expression in the intestinal-type gastric epithelial neoplasia: frequency and significance. Mod Pathol 2010; 23: 54-61
• 15 Guo RJ, Suh ER, Lynch JP. The role of Cdx proteins in intestinal development and cancer. Cancer Biol Ther 2004; 3: 593-601
• 16 Lauren P. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64: 31-49
• 17 Nawata Y, Yagi K, Tanaka M. et al. Reversal phenomenon on the mucosal borderline relates to development of gastric cancer after successful eradication of H. pylori. J Gastroenterol Hepatol Res 2017; 6: 1-6
• 18 Moribata K, Kato J, Iguchi M. et al. Endoscopic features associated with development of metachronous gastric cancer in patients who underwent endoscopic resection followed by Helicobacter pylori eradication. Dig Endosc 2016; 28: 434-442
• 19 Rugge M, Genta RM. Staging and grading of chronic gastritis. Hum Pathol 2005; 36: 228-233
• 20 Rugge M, Correa P, Di Mario F. et al. OLGA staging for gastritis: a tutorial. Dig Liver Dis 2008; 40: 650-658
• 21 Capelle LG, de Vries AC, Haringsma J. et al. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointestinal Endosc 2010; 71: 11150-1158
• 22 Saka A, Yagi K, Nimura S. OLGA- and OLGIM-based staging of gastritis using narrow-band imaging magnifying endoscopy. Dig Endosc 2015; 27: 735-742